Madera BioSciences, Inc.
First effective Alzheimer's drug will be an costly antibody. Madera is the small molecule alternative for cost-effective long-term therapy.
- Stage Prototype Ready
- Industry Biotechnology
- Location Rancho Santa Fe, CA, USA
- Currency USD
- Founded June 2008
- Employees 2
- Website maderabiosciences.com
Company Summary
Madera BioSciences is a startup biotechnology company founded by Edwin Iwanowicz, Ph.D. in 2008. The company provides innovative small molecule experimental therapeutics for the treatment of Alzheimer’s disease to pharma companies. Madera’s technology niche is to clear a key pathogen protein, amyloid beta. Our intellectual property resulted from a successful collaboration with Eli Lilly. The company have raised > $640K and seeks $2M.
Team
-
Richard M JackPresident and CEO
-
Spencer David KimballSenior Advisor, Drug Discovery
-
Edwin J. IwanowiczFounder
Advisors
-
WilmerHaleLawyerUnconfirmedCD GeidtAccountantUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.